Dxevo is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Skylar Laboratories, Llc. The primary component is Dexamethasone.
Product ID | 70362-702_879a3613-ac77-ef86-e053-2a95a90a7adf |
NDC | 70362-702 |
Product Type | Human Prescription Drug |
Proprietary Name | Dxevo |
Generic Name | Dexamethasone 1.5 Mg |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-03-25 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA201270 |
Labeler Name | Skylar Laboratories, LLC |
Substance Name | DEXAMETHASONE |
Active Ingredient Strength | 2 mg/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-03-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA201270 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-03-25 |
Ingredient | Strength |
---|---|
DEXAMETHASONE | 1.5 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
70362-702 | Dxevo | Dexamethasone 1.5 mg |
70362-707 | Dxevo | Dexamethasone 1.5 mg |
70569-151 | Dxevo | dexamethasone |
68047-702 | Dexamethasone | Dexamethasone 1.5 mg |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DXEVO 88334412 not registered Live/Pending |
LARKEN LABORATORIES, INC. 2019-03-11 |
DXEVO 88245240 not registered Live/Pending |
Innovate Research & Development, LLC 2018-12-29 |